| Date | Time | Source | Headline | Symbol | Company |
| 04/17/2024 | 12:00PM | iHub Newswire | FeaturedGlucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring | | |
| 12/14/2009 | 4:50PM | Marketwired | Pharmacom Biovet, Inc. Adds New Management | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 08/12/2009 | 9:00AM | Marketwired | Pharmacom Biovet Announces No Reverse Split | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 08/05/2009 | 8:56AM | Marketwired | PharmaCom BioVet, Inc. Announces Plan for Asset Sale With Dividend to Shareholders | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 07/08/2009 | 8:31AM | Marketwired | PharmaCom BioVet Establishing a Proprietary Canine DLA Registry | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 06/11/2009 | 8:31AM | Marketwired | PharmaCom BioVet, Inc. Begins to Review the Process to Potentially Receive Minor Use/Minor Species Drug Approval From FDA | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 06/04/2009 | 8:30AM | Marketwired | PharmaCom BioVet to File With FDA in Order to Perform Clinical Trials | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 04/22/2009 | 3:50PM | Marketwired | PharmaCom BioVet Receives "Target Price of 0.016" From Market Analysis Firm Market Advisors | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 04/01/2009 | 12:00AM | Marketwired | PharmaCom BioVet, Inc. Announces Joint Venture Agreement for Veterinary Cancer Compound | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 03/16/2009 | 3:34PM | Marketwired | PharmaCom BioVet, Inc. Comments on Speculation of Corporate Restructuring | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 03/11/2009 | 7:30AM | Marketwired | PharmaCom BioVet, Inc. Expands On Strategic Alliances | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 03/10/2009 | 10:24AM | Marketwired | PharmaCom BioVet, Inc. Provides Update On Corporate Development | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 01/09/2009 | 11:08AM | Marketwired | PharmaCom BioVet, Inc. Announces Its Plans to Establish Its First Branded Veterinary Oncology Treatment Center in the Columbia, | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 12/22/2008 | 9:35AM | Marketwired | PharmaCom BioVet, Inc. Announces Initial Locations for Its Branded Veterinary Oncology Treatment Centers | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 12/18/2008 | 9:15AM | Marketwired | PharmaCom BioVet, Inc. Begins Nationwide Rollout of Advanced Veterinary Oncology Centers | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 11/18/2008 | 5:25PM | Marketwired | PharmaCom BioVet, Inc. Announces Cancer Care Centers to Incorporate Significant Benefits of Lymphoma Blood Tests for Canine Canc | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 11/17/2008 | 4:15PM | Marketwired | PharmaCom BioVet, Inc. Collaborates With PetScreen, LTD, Leading Innovator of Canine Cancer Early Detection | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 11/10/2008 | 8:36AM | Marketwired | PharmaCom BioVet, Inc. to Provide Novel Canine Cancer Treatment Programs to Meet Exploding Pet Care Demand | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 10/23/2008 | 7:49PM | Marketwired | / CORRECTION - PharmaCom BioVet, Inc. | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 10/21/2008 | 8:30AM | Marketwired | PharmaCom BioVet, Inc. and IsoTherapeutics Group, LLC Announces Liquid Brachytherapy Planned for Canine Cancer Treatment Centers | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 10/15/2008 | 8:41AM | Marketwired | PharmaCom BioVet, Inc. Introduces Novel Cancer Treatments in Partnership With IsoTherapeutics Group | USOTC:PHMB | PharmaCom BioVet Inc (CE) |
| 10/08/2008 | 8:36AM | Marketwired | PharmaCom BioVet, Inc. Announces World's First Dedicated Veterinary Canine Bone Marrow Transplant Center | USOTC:PHMB | PharmaCom BioVet Inc (CE) |